ENTRY       D02908                      Drug
NAME        Aminolevulinic acid hydrochloride (JAN/USAN);
            5-Aminolevulinic acid hydrochloride;
            Levulan (TN);
            Ameluz (TN);
            Gleolan (TN)
PRODUCT     AMELUZ (Biofrontera)
            GLEOLAN (Medexus Pharma)
            LEVULAN KERASTICK (DUSA Pharmaceuticals)
FORMULA     C5H9NO3. HCl
EXACT_MASS  167.0349
MOL_WEIGHT  167.5908
REMARK      Therapeutic category: 7290
            ATC code: L01XD04
            Chemical structure group: DG00708
            Product (DG00708): D02908<JP/US>
EFFICACY    Diagnostic (malignant glioma), Photosensitizer
  DISEASE   Glioma [DS:H00042]
            Actinic keratosis [DS:H02429]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XD Sensitizers used in photodynamic/radiation therapy
                 L01XD04 Aminolevulinic acid
                  D02908  Aminolevulinic acid hydrochloride (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Warts and Actinic Keratosis Agents
                Aminolevulinic Acid
                 D02908  Aminolevulinic acid hydrochloride (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             7  Agents not mainly for therapeutic purpose
              72  Intracorporeal diagnostic agents
               729  Miscellaneous
                7290  Miscellaneous
                 D02908  Aminolevulinic acid hydrochloride (JAN/USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02908
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02908
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02908
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02908
DBLINKS     CAS: 5451-09-2
            PubChem: 17397065
            ChEBI: 132969
            LigandBox: D02908
            NIKKAJI: J257.039D
ATOM        10
            1   N1a N    11.5500   -5.7400
            2   C1b C    10.2900   -5.0400
            3   C5a C     9.1000   -5.7400
            4   C1b C     7.9100   -5.0400
            5   C1b C     6.6500   -5.7400
            6   C6a C     5.4600   -5.0400
            7   O6a O     4.2700   -5.7400
            8   O6a O     5.4600   -3.6400
            9   O5a O     9.1000   -7.1400
            10  X   Cl   15.0500   -5.8800
BOND        8
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     6   8 2
            8     3   9 2
///
